Technology 84 of 266
Drug delivery systems
6 EIC Accelerator winners build on Drug delivery systems, 1% of the classified companies, in 1 sector and 2 industries.
6
Companies
1
Sectors
2
Industries
5
Countries
0%
Exits
17%
Show signs of scaling
Sectors
- Health6 (100%)
Industries
Companies per year of first award
2019
2020
2021
2022
2023
2024
- Drug delivery systems
Show the numbers
| Companies | Drug delivery systems | |
|---|---|---|
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 2 | 2 |
| 2022 | 1 | 1 |
| 2023 | 1 | 1 |
| 2024 | 1 | 1 |
What happened to them (6 of 6 checked)
- Active4 (67%)
- Exit0 (0%)
- Failed1 (17%)
- Other1 (17%)
Signs of scaling
- Scaling1 (17%)
- Not scaling3 (50%)
- Scaling unclear2 (33%)
Countries
Keywords
- Affordable care
- Asherman syndrome
- CAR-T
- Convection-enhanced delivery
- Delayed cerebral ischaemia
- Diabetes
- DIPG
- Gene writing
- Global health
- Gynaecology
- Insulin pens
- Intracerebral haemorrhage
- Intrauterine adhesions
- Lipid nanoparticles
- Neurosurgery
- Oncology
- Orphan drugs
- Paediatric brain cancer
- Paediatric liver disease
- Panobinostat
- Stroke
- Subarachnoid haemorrhage
- Thrombolytics
- Transposases
- Uterine fibroids
All 6 companies using Drug delivery systems
| Company | Project | Industry | Country | Cut-off | Funding | Status | Rasph |
|---|---|---|---|---|---|---|---|
| INTEGRA THERAPEUTICS S.L. | FiCATNext generation gene writing platform to cure genetic and oncological diseases | Biopharmaceuticals | Spain | March 2024 | Blended finance | Active | Deep dive |
| Womed SAS | WOMEDWOMED: an innovative intrauterine biodegradable polymer-based drug-delivery platform | Medical devices | France | November 2023 | Grant first | Active | Deep dive |
| GO-Pen ApS | GO-PenThe first universal and price-neutral insulin pen | Medical devices | Denmark | June 2022 | Grant first | Active | Deep dive |
| Edvince AB | EDVanceEDV2209 – a Paradigm shift in the treatment of stroke. | Biopharmaceuticals | Sweden | October 2021 | Grant first | Active | Deep dive |
| Op2Lysis | OP2DRAINTo deliver the first medical treatment dedicated to patients with haemorrhagic stroke | Biopharmaceuticals | France | October 2021 | Blended finance | Insolvent | Deep dive |
| Biodexa Ltd | GlioKIDSDevelopment of MTX110 as a Convection Enhanced Delivery (CED) treatment for Diffuse Intrinsic Pontine Glioma (DIPG) in children | Biopharmaceuticals | United Kingdom | October 2019 | Blended finance | Pivoted | Deep dive |